Sienna Biopharmaceuticals, Inc. — Form D

Sienna Biopharmaceuticals, Inc. of Weslake Village, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-10-20. The offering totals $40.4M, of which $18.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Frederick BeddingfieldDirectorCarlsbad, CA
Kristina BurowDirectorSan Diego, CA
Todd HarrisDirectorSan Juan Capistrano, CA
Robert MoreDirectorCarlsbad, CA
Robert NelsonDirectorShreveport, LA
Todd HarrisExecutive OfficerSan Juan Capistrano, CA
Robert MoreExecutive OfficerCarlsbad, CA
Ted SchwarzExecutive OfficerCarlsbad, CA
Timothy K AndrewsExecutive OfficerSan Diego, CA
Dennis R FentonDirectorWestlake Village, CA
Bob R MoreDirectorWestlake Village, CA
Diane F StroehmannExecutive OfficerWestlake Village, CA
Frederick C Beddingfield IIIDirectorWestlake Village, CA
Frederick C Beddingfield IIIExecutive OfficerWestlake Village, CA
Paul F LizzulExecutive OfficerWestlake Village, CA
Ric C PetersonExecutive OfficerWestlake Village, CA
Keith R Leonard Jr.DirectorWestlake Village, CA
Todd C HarrisDirectorWestlake Village, CA
Todd C HarrisExecutive OfficerWestlake Village, CA
Robert R NelsenDirectorWestlake Village, CA
Kristina R BurowDirectorWestlake Village, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2017-05-15D$40.5M$40.5M
2017-05-15D/A$50.0M$46.6M

More